NCT07246863 2026-03-04Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCCatalYm GmbHPhase 2 Recruiting131 enrolled
NCT07098988 2026-02-27Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLCCatalYm GmbHPhase 2 Recruiting107 enrolled